Skip to main content
Equibles
ACOG logo

ACOG · Alpha Cognition Inc.

Track ACOG — free

Use ACOG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ACOG

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.41 -0.43 (-4.86%)
Market Cap
$192.52M
Shares
21.78M

Alpha Cognition Inc. Earnings Call Transcripts

Every quarterly earnings call for Alpha Cognition Inc. (ACOG) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $2.93M −$1.73M '25 Q1 25-03-31 ▼98.3% $1.66M −$13.20M '25 Q2 25-06-30 ▼97.2% $2.84M −$1.32M '25 Q3 25-09-30 · $2.79M −$4.43M '25 Q4 26-03-26 LATEST ▲20.7% $3.53M −$6.48M '26 Q1 26-03-31
Earnings call
FY26 · Q1
2026-03-31
Alpha Cognition Inc. Q1 FY2026 Earnings Call
Confident tone ZUNVEYL Commercial Launch Clinical / Real-World Evidence Programs Prescriber & Sales Force Growth
Revenue
$3.53M
▲ 20.7% YoY
Diluted EPS
$-0.32
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
Alpha Cognition Inc. Q4 FY2025 Earnings Call
Confident tone ZUNVEYL commercial launch and revenue growth Real-world evidence studies (BEACON, CONVERGE, RESOLVE) Long-term care adoption and prescriber expansion
Revenue
$2.79M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Alpha Cognition Inc. Q3 FY2025 Earnings Call
Confident tone ZUNVEYL commercial launch metrics International expansion via CMS Pharma in China Pricing and gross-to-net
Revenue
$2.84M
▼ 97.2% YoY
Diluted EPS
$-0.30
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Alpha Cognition Inc. Q2 FY2025 Earnings Call
Confident tone ZUNVEYL commercial launch Sublingual formulation R&D Healthcare professional engagement
Revenue
$1.66M
▼ 98.3% YoY
Diluted EPS
$-0.82
Gross margin
87.7%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Alpha Cognition Inc. Q1 FY2025 Earnings Call
Confident tone ZUNVEYL commercial launch Medicare reimbursement and access Intellectual property and patents
Revenue
$2.93M
Diluted EPS
$-0.11
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts CIK 1655923 CUSIP 02074J501 13F (30d) 26 filings 25 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)